Talk:FOLFOXIRI
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about FOLFOXIRI.
|
2016 opinion[edit]
Numerous Frontline CRC Options Allow Individualized Approach. April 2016 clinical trial results with VEGFR and EGFR inhibitors. - Rod57 (talk) 13:12, 27 April 2016 (UTC)